Medicare Part D prescription data for Hepatitis C drugs in 2014. This data set shows the 15 fold increased in Medicare’s spending on drugs to treat hepatitis C. The drugs cure the disease, but taxpayers are footing the bill.
Get the Data
- You can’t charge people money to look at the data, or sell advertising specifically against it.
- If you use the data for a printed table, chart, graphic or map, you must cite ProPublica, and link to us if you publish online.
- You acknowledge that the data you use may contain errors and omissions, and you are solely responsible for checking our site for any corrections or updates.